Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Pancreatic NeoplasmsDNA MethylationProteome
Interventions
DIAGNOSTIC_TEST

cfDNA methylation sequencing and proteome analysis

Sequencing of cfDNA methylation and proteomic analysis of two sets of capsular fluid samples

Trial Locations (1)

200433

RECRUITING

Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

Oriental Hepatobiliary Surgery Hospital Affiliated to Naval Military Medical University

UNKNOWN

collaborator

Zhejiang University

OTHER

collaborator

The First Affiliated Hospital of Nanchang University

OTHER

collaborator

West China Hospital

OTHER

collaborator

LanZhou University

OTHER

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

collaborator

Peking University Cancer Hospital & Institute

OTHER

collaborator

First Hospital of China Medical University

OTHER

collaborator

First Affiliated Hospital of Guangxi Medical University

OTHER

collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

collaborator

The Second Affiliated Hospital of Baotou Medical College

OTHER

collaborator

Shandong Province Third hospital

OTHER

lead

Zhaoshen Li

OTHER